GIRC - Intégrité du génome, ARN et cancer

Type: Research entity evaluation report

Evaluation campaign: 2024-2025 (group E) - Published on: 15/04/2025

Institution(s) concerned: Institut Curie , Centre national de la recherche scientifique - CNRS , Université Paris Saclay

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE3 Microbiology, Virology, Immunity

ERC panel(s): LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS2 Genetics, Genomics, Bioinformatics and Systems Biology: genetics, population genetics, molecular genetics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, computational biology, biostatistics, biological modelling and simulation, ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome

Keywords: Bloom syndrome { cytidine deaminase { genetic instability ; nucleotide pool disequilibrium ; carcinogenesis ; anti-cancer therapy ; DNA Damage Response ; Cancer ; Replication ; Recombination ; RNA